Skip to main content
SpringerLink
Log in

Alectinib/iodine-131

Lack of efficacy, facial oedema and rash: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lee H, et al. Case Report of CCDC149-ALK Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma. Thyroid 32: 1580-1585, No. 12, Dec 2022. Available from: URL: http://doi.org/10.1089/thy.2022.0389

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alectinib/iodine-131. Reactions Weekly 1953, 20 (2023). https://doi.org/10.1007/s40278-023-37455-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-37455-5

Search

Navigation